发明申请
- 专利标题: BSL2v2c2-Ig POLYPEPTIDES
-
申请号: US16778159申请日: 2020-01-31
-
公开(公告)号: US20200369744A1公开(公告)日: 2020-11-26
- 发明人: Glen Eugene Mikesell , Han Chang , Robert James Peach
- 申请人: Bristol-Myers Squibb Company
- 主分类号: C07K14/705
- IPC分类号: C07K14/705 ; C07K16/28 ; C07K19/00 ; A61K38/17 ; A61K39/395 ; G01N33/50
摘要:
The present invention provides nucleic acids encoding B7-related factors that modulate the activation of immune or inflammatory response cells, such as T-cells. Also provided are expression vectors and fusion constructs comprising nucleic acids encoding B7-related polypeptides, including BSL1, BSL2, and BSL3. The present invention further provides isolated B7-related polypeptides, isolated fusion proteins comprising B7-related polypeptides, and antibodies that are specifically reactive with B7-related polypeptides, or portions thereof. In addition, the present invention provides assays utilizing B7-related nucleic acids, polypeptides, or peptides. The present invention further provides compositions of B7-related nucleic acids, polypeptides, fusion proteins, or antibodies that are useful for the immunomodulation of a human or animal subject.
信息查询